N06AX (Other antidepressants)
GPTKB entity
Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:ATC_code
|
| gptkbp:ATCCode |
gptkb:N06AX
|
| gptkbp:class |
gptkb:Anatomical_Therapeutic_Chemical_Classification_System
|
| gptkbp:countryOfOperation |
Worldwide
|
| gptkbp:definedIn |
WHO ATC Classification System
|
| https://www.w3.org/2000/01/rdf-schema#label |
N06AX (Other antidepressants)
|
| gptkbp:includes |
N06AX03 (Mianserin)
N06AX05 (Trazodone) N06AX11 (Mirtazapine) N06AX12 (Nefazodone) N06AX16 (Bupropion) N06AX18 (Reboxetine) N06AX21 (Agomelatine) N06AX22 (Vortioxetine) N06AX23 (Vilazodone) N06AX26 (Tianeptine) N06AX27 (Opipramol) N06AX28 (Hypericum perforatum) |
| gptkbp:partOf |
gptkb:N06A_(Antidepressants)
|
| gptkbp:therapeuticArea |
Depression
|
| gptkbp:usedIn |
gptkb:Psychiatry
|
| gptkbp:bfsParent |
gptkb:N06AX16
|
| gptkbp:bfsLayer |
7
|